Norvēģija -
norvēģu -
Statens legemiddelverk
cepetor vet 1 mg/ ml
cp-pharma handelsgesellschaft mbh - medetomidinhydroklorid - injeksjonsvæske, oppløsning - 1 mg/ ml
Norvēģija -
norvēģu -
Statens legemiddelverk
dorbene vet 1 mg/ ml
laboratorios syva s.a.u. - medetomidinhydroklorid - injeksjonsvæske, oppløsning - 1 mg/ ml
Norvēģija -
norvēģu -
Statens legemiddelverk
fenazon-koffein 500 mg / 100 mg
orifarm healthcare a/s - fenazon / koffein - tablett - 500 mg / 100 mg
Norvēģija -
norvēģu -
Statens legemiddelverk
fenazon-koffein sterke 1 g / 100 mg
orifarm healthcare a/s - fenazon / koffein - tablett - 1 g / 100 mg
Norvēģija -
norvēģu -
Statens legemiddelverk
medodin vet 1 mg/ ml
eurovet animal health bv - medetomidinhydroklorid - injeksjonsvæske, oppløsning - 1 mg/ ml
Norvēģija -
norvēģu -
Statens legemiddelverk
natriumklorid-glucos baxter viaflo 4.5 mg/ ml / 25 mg/ ml
baxter medical ab - natriumklorid / glukosemonohydrat - infusjonsvæske, oppløsning - 4.5 mg/ ml / 25 mg/ ml
Norvēģija -
norvēģu -
Statens legemiddelverk
sedivet vet 10 mg/ ml
boehringer ingelheim vetmedica gmbh - romifidinhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
isemid
ceva santé animale - torasemide - high-ceiling diuretika, sulfonamider, vanlig - hunder - for behandling av kliniske tegn er relatert til hjertesvikt hos hund, blant annet lungeødem.
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
lysakare
advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - stråling skader - detoxifying agents for antineoplastic treatment - lysakare er indikert for reduksjon av nyre-stråling i løpet av peptid-reseptor radionuklide terapi (prrt) med lutetium (177lu) oxodotreotide i voksne.
Eiropas Savienība -
norvēģu -
EMA (European Medicines Agency)
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastiske midler - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.